lixisenatide - Resultados de la búsqueda

Unión Europea - español - EMA (European Medicines Agency)

suliqua

sanofi winthrop industrie - la insulina glargina, lixisenatide - diabetes mellitus, tipo 2 - drogas usadas en diabetes - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.

Unión Europea - español - EMA (European Medicines Agency)

lyxumia

sanofi winthrop industrie - lixisenatida - diabetes mellitus, tipo 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

soliqua ® insulina glargina 100 u/ml y lixisenatida 50 µg/ml solucion inyectable

sanofi - aventis del peru s.a. - droguerÍa - insulina glargina lixisenatida - solucion inyectable - 100 u/ml y 50 µg/ml - por cartucho 1.00 ml - - insulina asparta

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

soliqua insulina glargina 100 u/ml y lixisenatida 33 µg/ml solucion inyectable

sanofi - aventis del peru s.a. - droguerÍa - insulina glargina lixisenatida - solucion inyectable - 100 u/ml y 33 ug/ml - por cartucho 1.00 ml - - insulina asparta